Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement
Recruiting
Observational Study
Takayasu Arteritis With Pulmonary Artery Involvement
Percutaneous Transluminal Pulmonary Angioplasty
PAH Targeted Medication
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- Chinese Pulmonary Vascular Disease Research Group · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
1. Evaluate the effect of medical treatment and percutaneous transluminal pulmonary angioplasty on takayasu arteritis with pulmonary artery involvement 2. evaluate the efficacy of FAPI in predicting the activity and treatment efficacy of takayasu arteritis with pulmonary artery involvement
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* patients diagnosed with Takayasu arteries with pulmonary arteries involvement
Exclusion Criteria:
* Patients had pulmonary artery stenosis arising from CTEPH, fibrosing mediastinitis and congenital pulmonary artery stenosis
Contacts